PI3K/SGK1/GSK3β signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide

Experimental Cell Research

Volumn 345, Issue 2, 2016, Pages 134-140

  Jiang, Huan ^a   Xiao, Jian ^a   Kang, Bo ^a   Zhu, Xiaoyan ^b   Xin, Ni ^b   Wang, Zhinong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Cardiomyocyte; GSK3 ; H2S; Hypoxia reoxygenation; PI3K; SGK1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN SULFIDE; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SMALL INTERFERING RNA; CARDIOTONIC AGENT; IMMEDIATE EARLY PROTEIN; OXYGEN; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGY; CARDIAC MUSCLE CELL; CELL DAMAGE; CELL VIABILITY; ENZYME ACTIVITY; HEART PROTECTION; IN VITRO STUDY; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REOXYGENATION; SIGNAL TRANSDUCTION; ANIMAL; CELL HYPOXIA; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; AUTOPHAGY; CARDIOTONIC AGENTS; CELL HYPOXIA; GLYCOGEN SYNTHASE KINASE 3 BETA; HYDROGEN SULFIDE; IMMEDIATE-EARLY PROTEINS; MYOCYTES, CARDIAC; OXYGEN; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84961601038     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.07.005     Document Type: Article

References (34)

1. [1] Sivaraman, V., Yellon, D.M., Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. J. Cardiovasc. Pharmacol. Ther. 19 (2014), 83–96.
2. [2] Xiao, J., Zhu, X., He, B., Zhang, Y., Kang, B., Wang, Z., Ni, X., MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II. J. Biomed. Sci., 18, 2011, 35.
3. [3] Galluzzi, L., Morselli, E., Vicencio, J.M., Kepp, O., Joza, N., Tajeddine, N., Kroemer, G., Life, death and burial: multifaceted impact of autophagy. Biochem. Soc. Trans. 36 (2008), 786–790.
4. [4] Hamacher-Brady, A., Brady, N.R., Logue, S.E., Sayen, M.R., Jinno, M., Kirshenbaum, L.A., Gottlieb, R.A., Gustafsson, A.B., Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 14 (2007), 146–157.
5. [5] Hamacher-Brady, A., Brady, N.R., Gottlieb, R.A., Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 281 (2006), 29776–29787.
6. [6] Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., Sadoshima, J., Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100 (2007), 914–922.
7. [7] Hariharan, N., Zhai, P., Sadoshima, J., Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid. Redox Signal. 14 (2011), 2179–2190.
8. [8] Nishida, K., Kyoi, S., Yamaguchi, O., Sadoshima, J., Otsu, K., The role of autophagy in the heart. Cell Death Differ. 16 (2009), 31–38.
9. [9] Liu, Y.H., Lu, M., Hu, L.F., Wong, P.T., Webb, G.D., Bian, J.S., Hydrogen sulfide in the mammalian cardiovascular system. Antioxid. Redox Signal. 17 (2012), 141–185.
10. [10] Pan, L.L., Liu, X.H., Gong, Q.H., Yang, H.B., Zhu, Y.Z., Role of cystathionine gamma-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?. Antioxid. Redox Signal. 17 (2012), 106–118.
11. [11] Osipov, R.M., Robich, M.P., Feng, J., Chan, V., Clements, R.T., Deyo, R.J., Szabo, C., Sellke, F.W., Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interact. Cardiovas. Thorac. Surg. 10 (2010), 506–512.
12. [12] Matsui, T., Li, L., del Monte, F., Fukui, Y., Franke, T.F., Hajjar, R.J., Rosenzweig, A., Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100 (1999), 2373–2379.
13. [13] Hausenloy, D.J., Yellon, D.M., Cardioprotective growth factors. Cardiovas. Res. 83 (2009), 179–194.
14. [14] Matsui, T., Tao, J., del Monte, F., Lee, K.H., Li, L., Picard, M., Force, T.L., Franke, T.F., Hajjar, R.J., Rosenzweig, A., Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104 (2001), 330–335.
15. [15] Ravikumar, B., Sarkar, S., Davies, J.E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z.W., Jimenez-Sanchez, M., Korolchuk, V.I., Lichtenberg, M., Luo, S., Massey, D.C., Menzies, F.M., Moreau, K., Narayanan, U., Renna, M., Siddiqi, F.H., Underwood, B.R., Winslow, A.R., Rubinsztein, D.C., Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 90 (2010), 1383–1435.
16. [16] Nagoshi, T., Matsui, T., Aoyama, T., Leri, A., Anversa, P., Li, L., Ogawa, W., del Monte, F., Gwathmey, J.K., Grazette, L., Hemmings, B.A., Kass, D.A., Champion, H.C., Rosenzweig, A., PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Investig. 115 (2005), 2128–2138.
17. [17] Park, J., Leong, M.L., Buse, P., Maiyar, A.C., Firestone, G.L., Hemmings, B.A., Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J. 18 (1999), 3024–3033.
18. [18] Aoyama, T., Matsui, T., Novikov, M., Park, J., Hemmings, B., Rosenzweig, A., Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 111 (2005), 1652–1659.
19. [19] Tong, H., Imahashi, K., Steenbergen, C., Murphy, E., Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase–dependent pathway is cardioprotective. Circ. Res. 90 (2002), 377–379.
20. [20] Zhai, P., Sciarretta, S., Galeotti, J., Volpe, M., Sadoshima, J., Differential roles of GSK-3beta during myocardial ischemia and ischemia/reperfusion. Circ. Res. 109 (2011), 502–511.
21. [21] Hu, Y., Chen, X., Pan, T.T., Neo, K.L., Lee, S.W., Khin, E.S., Moore, P.K., Bian, J.S., Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflug. Archiv: Eur. J. Physiol. 455 (2008), 607–616.
22. [22] Zhou, X., Zhao, L., Mao, J., Huang, J., Chen, J., Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2. Toxicol. Sci.:Off. J. Soc. Toxicol., 2014.
23. [23] Padiya, R., Chowdhury, D., Borkar, R., Srinivas, R., Pal Bhadra, M., Banerjee, S.K., Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/Nrf2-Keap1 pathway in fructose-fed diabetic rat. PloS One, 9, 2014, e94228.
24. [24] Patten, R.D., Pourati, I., Aronovitz, M.J., Baur, J., Celestin, F., Chen, X., Michael, A., Haq, S., Nuedling, S., Grohe, C., Force, T., Mendelsohn, M.E., Karas, R.H., 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ. Res. 95 (2004), 692–699.
25. [25] Gomez, L.A., Alekseev, A.E., Aleksandrova, L.A., Brady, P.A., Terzic, A., Use of the MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. J. Mol. Cell. Cardiol. 29 (1997), 1255–1266.
26. [26] Cong, B., Wang, L., Zhu, X., Li, X., Liu, B., Ni, X., SGK1 is involved in cardioprotection of urocortin-1 against hypoxia/reoxygenation in cardiomyocytes. Can. J. Cardiol. 30 (2014), 687–695.
27. [27] Yitzhaki, S., Huang, C., Liu, W., Lee, Y., Gustafsson, A.B., Mentzer, R.M. Jr., Gottlieb, R.A., Autophagy is required for preconditioning by the adenosine A1 receptor-selective agonist CCPA. Basic Res. Cardiol. 104 (2009), 157–167.
28. [28] Jin, M., Klionsky, D.J., Transcriptional regulation of ATG9 by the Pho23-Rpd3 complex modulates the frequency of autophagosome formation. Autophagy 10 (2014), 1681–1682.
29. [29] Klionsky, D.J., Abdalla, F.C., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8 (2012), 445–544.
30. [30] Cantley, L.C., The phosphoinositide 3-kinase pathway. Science 296 (2002), 1655–1657.
31. [31] Petiot, A., Ogier-Denis, E., Blommaart, E.F., Meijer, A.J., Codogno, P., Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275 (2000), 992–998.
32. [32] Juhaszova, M., Zorov, D.B., Yaniv, Y., Nuss, H.B., Wang, S., Sollott, S.J., Role of glycogen synthase kinase-3beta in cardioprotection. Circ. Res. 104 (2009), 1240–1252.
33. [33] Cheng, H., Woodgett, J., Maamari, M., Force, T., Targeting GSK-3 family members in the heart: a very sharp double-edged sword. J. Mol. Cell. Cardiol. 51 (2011), 607–613.
34. [34] Yao, L.L., Huang, X.W., Wang, Y.G., Cao, Y.X., Zhang, C.C., Zhu, Y.C., Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Am. J. Physiol. Heart Circ. Physiol. 298 (2010), H1310–H1319.